Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Mohamed Allaf: Aspirin and Clopidogrel Show Comparable Long-Term Survival After TAVI
Aug 9, 2026, 18:03

Mohamed Allaf: Aspirin and Clopidogrel Show Comparable Long-Term Survival After TAVI

Mohamed Allaf, Associate College Tutor at Royal College of Physician, Director of Specialtyapp, Internal Medicine Residency at NHS England, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in adding:

“To the best of our knowledge, this is the largest study comparing aspirin versus clopidogrel following TAVI.

Our analysis showed comparable long-term survival in patients treated with either aspirin or clopidogrel.

Further randomized trials are required for the validation of our results.”

Title: Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis

Article: Anastasios Apostolos, Konstantinos Konstantinou, Mohammed Allaf, Athanasios Sakalidis, Konstantinos Kalogeras, Ee Ling Heng, Simon Davies, Alison Duncan, Miles Dalby, Saeed Mirsadraee, Tarun Mittal, Aigul Baltabaeva, Tito Kabir, Mohammed Majid Akhtar, Robert Smith, Vasileios Panoulas

Mohammed Allaf

Stay updated on all scientific advances with Hemostasis Today.